CMP: $92

Allergan, Inc. is a multi-specialty health care company that develops and commercializes pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets globally.

Allergan is nearly a $28 Billion market cap company trading at a P/E of 27. Revenues have risen from $4.50 Billion to $5.42 Billion in the last 2 years. Profits have risen from $621 Million to $934 Million in the last 2 years. Profit margins have risen from 14% to 17% in the last 2 years. With a well balanced long term debt, it looks a good buy.